Clik here to view.
E-Qure wins FDA nod for bio-electrical signal wound therapy
Chronic wound treatment device developer E-Qure said today it won FDA investigational device exemption approval to conduct a clinical trial of its novel Bio-Electrical Signal Therapy device. The New...
View ArticleClik here to view.
Baxter launches pivotal trial for citrate anticoagulant-renal replacement...
Baxter (NYSE:BAX) said today it launched a Phase 3 clinical trial of an investigational drug combining a citrate anticoagulant and renal replacement solution. The trial will explore whether the use of...
View ArticleClik here to view.
DexCom, Tandem Diabetes dive on Q3 misses
Shares in both Tandem Diabetes Care (NSDQ:TNDM) and Dexcom Inc. (NSDQ:DXCM) took a dive today after the companies released 3rd quarter earnings results that missed expectations from analysts on Wall...
View ArticleClik here to view.
Singapore Medical Device Regulators Target Telehealth
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: Singapore’s Health Sciences Authority (HSA) is proposing a clearer approach to regulating mobile medical apps and telehealth products as...
View ArticleClik here to view.
Smith & Nephew dips on Q3 sales numbers
Smith & Nephew (NYSE:SNN) shares dipped today after the British orthopedics and wound care giant reported 3rd-quarter sales that just met expectations. Revenues were up 1.3% to $1.12 billion for...
View ArticleClik here to view.
Boston Scientific buys LumenR’s tissue retractor
Boston Scientific (NYSE:BSX) said today that it paid an unspecified amount for a tissue retractor developed by LumenR for endoscopic resection of the gastrointestinal tract. The Newark, Calif.-based...
View ArticleClik here to view.
Prioritizing patient preference & risk in device trials
Patients with a rare, chronic disease can find themselves in a conundrum when seeking treatment: Researchers can’t find enough patients to enroll in a statistically rigorous clinical trial and there is...
View ArticleClik here to view.
Wright Medical jumps on $240m hip settlement, Q3 results
Wright Medical (NSDQ:WMGI) shares are up nearly 4% today after the orthopedics company yesterday said it inked a $240 million settlement this month for nearly 1,300 product liability lawsuits brought...
View ArticleClik here to view.
Incoming Getinge CEO Perjos has industrial background
(Reuters) — Swedish medical technology firm Getinge (PINK:GETI B) said today that it found a new CEO, sending up its battered shares, but some analysts said the incoming industrialist lacked the...
View ArticleClik here to view.
Encapsulating single cells in tunable hydrogel could boost cell therapies
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences have developed a microfluidic...
View ArticleClik here to view.
Report: Valeant explores sales of eye surgery biz
Valeant Pharmaceuticals (NYSE:VRX) is reportedly exploring a sale of its eye surgery business that could be worth as much as $2.5 billion. The sale process is still in early stages and may not even...
View ArticleClik here to view.
West Virginia wants Justice Dept. to nix Mylan settlement
(Reuters) – West Virginia Attorney General Patrick Morrisey on Wednesday blasted a pending $465 million settlement between Mylan NV (NSDQ:MYL) and the U.S. Justice Dept. over the misclassification of...
View ArticleClik here to view.
Novocure reports 142% boost in sales for Q3
Shares in Novocure (NSDQ:NVCR) rose nearly 30% yesterday after the medical device maker met expectations on Wall Street with its 3rd-quarter results. The St. Helier, N.J.-based company pared its losses...
View ArticleClik here to view.
TissueGene subsidiary inks development deal for osteoarthritis injection
TissueGene licensee Kolon Life Science (KSDQ:102940) of Korea said this week that it inked a deal with Japan’s Mitsubishi Tanabe Pharma Corp. (TYO:4508) to develop and commercialize Kolon’s Invossa,...
View ArticleClik here to view.
General Atlantic gets in on Synaptive Medical
Synaptive Medical said today that growth equity firm General Atlantic has made a strategic investment of an undisclosed amount in the company. The Toronto-based medical device company said the...
View ArticleClik here to view.
Becton Dickinson’s full-year profits soar 40%
Becton Dickinson (NYSE:BDX) shares gained nearly 4% today after the medical products giant posted fiscal 4th-quarter and full-year results that met or beat the consensus forecast on Wall Street....
View ArticleClik here to view.
Third Rock Ventures raises $600m fund
Healthcare venture capital firm Third Rock Ventures said today it raised $616 million for its new oversubscribed Fund IV, which will support innovative healthcare companies. The new investment round...
View ArticleClik here to view.
NxStage soars on Street-beating Q3
Shares in NxStage Medical (NSDQ:NXTM) rose today after the device maker beat expectations on Wall Street with its 3rd quarter results. The Lawrence, Mass.-based company posted losses of $890,000, or 0¢...
View ArticleClik here to view.
RSP Systems wins $2.7m grant for GlucoBeam glucose monitor
RSP Systems said today it won a $2.7 million (EU €2.4 million) grant to support the commercial launch of its GlucoBeam non-invasive glucose monitor. The grant comes as part of the European Union’s...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 3, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article
